Stock listing

LIMN Stock Price, News, Filings & Events — Liminatus Pharma, Inc.

Selected listing: LIMN · BOATS · USD · US

This page tracks Liminatus Pharma, Inc.'s LIMN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LIMN:BOATS. LIMN:BOATS is the stock-level entry point for investors researching Liminatus Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Liminatus Pharma, Inc. is a public company traded under the ticker LIMN in the American market. The company has a market capitalization of approximately $7.45 million. Liminatus Pharma focuses on developing innovative pharmaceutical solutions.

LIMN:BOATSUSDUSUpdated September 11, 2026
Liminatus Pharma, Inc. logo
Ticker
LIMN:BOATS
Asset type
Stock
Market cap
$4.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Liminatus Pharma, Inc. LIMN:BOATS stock context

This page tracks Liminatus Pharma, Inc.'s LIMN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LIMN:BOATS. LIMN:BOATS is the stock-level entry point for investors researching Liminatus Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Liminatus Pharma, Inc. is a public company traded under the ticker LIMN in the American market. The company has a market capitalization of approximately $7.45 million. Liminatus Pharma focuses on developing innovative pharmaceutical solutions.

Latest news from Liminatus Pharma, Inc.

All Liminatus Pharma, Inc. news →

Research Liminatus Pharma, Inc.

Alternate listings